Month: March 2026

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< 0.05) Potential 2X treatment benefit compared to 15% and 22% reductions reported for currently approved therapies at 12 and 24 months, respectively No serious adverse events and no adverse events of special interest related to OCU410 reported to dateMALVERN, Pa., March 24, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced positive 12-month data from the Phase 2 ArMaDa clinical trial evaluating OCU410 (AAV5-RORA), its novel modifier gene therapy for geographic atrophy (GA) secondary to dry age-related macular degeneration (dAMD). The global prevalence of dAMD is 266 million...

MONTREAL, Quebec, March 24, 2026 (GLOBE NEWSWIRE) — NanoXplore Inc. (“NanoXplore”) (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, is pleased to announce the publication of its first Sustainability Report, covering our fiscal year 2025. This report represents a significant leap towards deepening our insight into environmental impacts, strengthening our social commitments, and further integrating sustainability into every aspect of our business. Key highlights:Integration of a sustainability data management software. Improvement of our GHG emission management. Health & Safety practices. Continuous investment in Research & Development.“Our commitment in sustainability is evident by the advancement of several key initiatives. This milestone publication underscores the company’s dedication to transparency,...

TORONTO, March 24, 2026 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) today announced the March 2026 cash distributions for AGF Enhanced U.S. Equity Income Fund*, AGF Total Return Bond Fund* and AGF Systematic Global Infrastructure ETF, which pay monthly distributions, as well as AGF Global Sustainable Growth Equity ETF, which pays quarterly distributions. Unitholders of record on March 31, 2026 will receive cash distributions payable on April 7, 2026.  Details regarding the final “per unit” distribution amounts are as follows:ETF Ticker Exchange  Cash Distribution Per Unit ($)AGF Enhanced U.S. Equity Income Fund* AENU Cboe Canada Inc.  $0.181280AGF Total Return Bond Fund* ATRB Cboe Canada Inc.  $0.140000AGF Systematic Global Infrastructure ETF QIF Cboe Canada Inc.  $0.169008AGF Global Sustainable...

MONTREAL, March 24, 2026 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor“ or the “Corporation“) announced today that its Board of Directors has approved a monthly dividend of C$0.01333 per common share (C$0.16 annually) for April 2026. This will be payable on April 17, 2026, to shareholders of record as of the close of business on April 9, 2026. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes. The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. About Dynacor Dynacor Group is an ore processing company dedicated to producing gold sourced from artisanal miners. Since its establishment in 1996,...

WAYNE, Pa., March 24, 2026 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc. (“Palvella” or “the Company”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced that the Company will report its full year 2025 financial results before market open on Tuesday, March 31, 2026. Palvella management will host a conference call for investors at 8:30 a.m. ET on that same day to discuss the results and provide a corporate update. To access the live webcast of the call with slides, please click here or visit the “Events & Presentations” section of Palvella’s website. To access the...

HydroGraph’s fractal graphene undergoing testing within ecosparc® additives designed to extend the life of steel assets in harsh environments Partnership Targets US$33 Billion Protective Coatings Market VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (CSE: HG) (OTCQB: HGRAF) (“HydroGraph” or the “Company”) today announced that it has entered into a Letter of Intent (“LOI”) dated March 23, 2026 with Sparc Technologies Limited (ASX: SPN) (FRA: NLR) (“Sparc”) to collaborate on the incorporation of HydroGraph’s Fractal Graphene™ into Sparc’s ecosparc® additives for protective coatings. The LOI establishes a framework for joint testing, product development, and the potential commercial supply of graphene for ecosparc® additives. Subject to successful performance outcomes, the parties...

WEST DES MOINES, Iowa, March 24, 2026 (GLOBE NEWSWIRE) — Athene, the leading retirement solutions company and subsidiary of Apollo Global Management, Inc. (NYSE:APO), ranked number one in LIMRA’s 2025 U.S. Retail Annuity Survey for the third consecutive year, reinforcing the company’s leadership position as the top provider of guaranteed income solutions. “Athene’s market leadership reflects the strength of the model we’ve built to serve our distribution partners and their clients,” said Sean Brennan, Co-President and Chief Commercial Officer, Athene USA. “The need for solutions that provide reliable retirement income remains clear, and Athene’s retail annuities continue to play an important role in helping individuals achieve greater financial security in retirement.” Athene also ranked number one in several categories, including:Total...

DENVER, March 24, 2026 (GLOBE NEWSWIRE) — Intermap Technologies (TSX: IMP; OTCQB: ITMSF) (“Intermap” or the “Company”), a global leader in 3D geospatial products and intelligence solutions, today announced that it will release its fourth quarter and full year 2025 financial results after market close on March 31, 2026. Intermap’s CEO Patrick A. Blott and CFO Jennifer Bakken will host a live webinar that same day at 5:00 pm ET to review the Company’s financial results and answer investor questions following the presentation. Intermap welcomes shareholders, analysts, investors, media representatives, and other stakeholders to attend the webinar to discuss fourth quarter and full year 2025 results. Conference Call DetailsDATE   March 31, 2026TIME   5:00 pm ETWEBCAST   Register     A replay of the webinar and supporting...

Delivered record net revenue of $59.5 million for 2025 (22% increase from 2024) and record quarterly net revenue of $16.5 million in Q4 2025 (up 16% from Q4 2024);Adjusted EBITDA1 of $5.0 million (25% increase from 2024) for the year ended December 31, 2025;Generated income from operations of $1.8 million, representing a turnaround from a loss of $1.2 million in 2024;Rapid scale-up of the Cascadia Facility with first harvests completed in February 2026.VANCOUVER, British Columbia, March 24, 2026 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), Canada’s leading premium licensed producer focused on cultivating and selling premium and super-premium cannabis products, announces it has reported its financial results for the year ended December 31, 2025. All financial...

Delivers revenue and profit within guidance Maintains consistent full year outlook Strong momentum in iX Suite enterprise winsNEWARK, Calif., March 24, 2026 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced financial results for the fiscal first quarter ended February 28, 2026.  Three Months Ended      February 28, 2026   February 28, 2025   ChangeRevenue($M) $ 2,500.4     $ 2,372.2     5.4 %Operating income($M) $ 118.6     $ 168.9     (29.8)%Non-GAAP operating income($M)(1) $ 295.0     $ 321.5     (8.2)%Operating margin   4.7 %     7.1 %   -240 bpsNon-GAAP operating margin(1)   11.8 %     13.6 %   -180 bpsNet income($M) $ 21.6     $ 70.3     (69.3)%Non-GAAP net income($M)(1) $ 168.2     $ 188.1     (10.6)%Adjusted EBITDA($M)(1) $ 348.2     $ 374.2     (6.9)%Adjusted...